Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial

BACKGROUND: Typhoid fever is an endemic disease in many low-income and middle-income countries. The 2018 WHO position paper recommends that countries should consider typhoid vaccination in high-risk groups and for outbreak control. To address the typhoid vaccine supply and demand gap, a typhoid Vi p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar Rai, Ganesh, Saluja, Tarun, Chaudhary, Shipra, Tamrakar, Dipesh, Kanodia, Piush, Giri, Bishnu Rath, Shrestha, Rajeev, Uranw, Surendra, Kim, Deok Ryun, Yang, Jae Seung, Park, Il-Yeon, Kyung, Seung-Eun, Vemula, Sridhar, Reddy E, Jagadeesh, Kim, Bomi, Gupta, Birendra Prasad, Jo, Sue Kyoung, Ryu, Ji Hwa, Park, Ho Keun, Shin, Jong Hoon, Lee, Yoonyeong, Kim, Hun, Kim, Jerome H, Mojares, Zenaida Reynoso, Wartel, T Anh, Sahastrabuddhe, Sushant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942857/
https://www.ncbi.nlm.nih.gov/pubmed/34942090
http://dx.doi.org/10.1016/S1473-3099(21)00455-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942857/
https://www.ncbi.nlm.nih.gov/pubmed/34942090
http://dx.doi.org/10.1016/S1473-3099(21)00455-2

Ejemplares similares